133 related articles for article (PubMed ID: 2583456)
1. [Immunocytochemical methods using monoclonal antibodies and lectins in the diagnosis of lymphoblastic leukemia in children].
Gluzman DF; Sidorenko SP; Berdova AG; Skliarenko LM; Nadgornaia VA; Abramenko IV; Poludnenko LIu; Drozdova VD
Gematol Transfuziol; 1989 Sep; 34(9):20-3. PubMed ID: 2583456
[TBL] [Abstract][Full Text] [Related]
2. [Immunoenzyme cytochemical methods, monoclonal antibodies and lectins in the diagnosis of tumors of the lymphoid tissue in children].
Gluzman DF; Nadgornaia VA; Skliarenko LM; Abramenko IV; Sidorenko SP; Kaz'mina EV; Livshits EA; Drozdova VD
Pediatriia; 1991; (11):18-22. PubMed ID: 1766734
[TBL] [Abstract][Full Text] [Related]
3. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
[No Abstract] [Full Text] [Related]
4. The significance of phenotyping leukemias using monoclonal antibodies.
Pombo-de-Oliveira MS; Tabak DG
Braz J Med Biol Res; 1990; 23(9):763-72. PubMed ID: 2101315
[TBL] [Abstract][Full Text] [Related]
5. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic variants of acute lymphoblastic leukemia in adults and its correlation with cytochemical and various clinical parameters].
Bulycheva TI; Novikova MS; Miterev GIu; Shakhbazian GP; Novikova NN
Gematol Transfuziol; 1989 May; 34(5):13-9. PubMed ID: 2787263
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies of the ICO series in immunologic classification of lymphoblastic tumors in children].
Baryshnikov AIu; Tupitsyn NN
Pediatriia; 1991; (11):15-8. PubMed ID: 1766733
[TBL] [Abstract][Full Text] [Related]
8. [The current criteria of cell identification in acute lymphoblastic leukemia].
Muskhelishvili LV; Muskhelishvil GD; Sharashidze LK
Eksp Onkol; 1989; 11(1):6-11. PubMed ID: 2647463
[TBL] [Abstract][Full Text] [Related]
9. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
[TBL] [Abstract][Full Text] [Related]
10. [Effects of immunologic markers on prognosis in acute lymphoblastic leukemia in young children].
Balakirev SA; Makhonova LA; Tupitsyn NN; Baryshnikov AIu; Artem'ev AK; Maiakova SA; Kadagidze ZG
Pediatriia; 1991; (11):37-9. PubMed ID: 1766737
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic cell markers in acute lymphoblastic leukemia in children].
Grigor'iants LIa
Eksp Onkol; 1987; 9(2):28-30. PubMed ID: 3495426
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies of the ICO series against differentiation antigens of human lymphocytes].
Baryshnikov AIu
Gematol Transfuziol; 1990 Aug; 35(8):4-7. PubMed ID: 2253863
[TBL] [Abstract][Full Text] [Related]
13. [Panel of monoclonal antibodies to CD38 antigen].
Baryshnikov AIu; Dubinkin IV; Korotkova OV; Tupitsyn NN; Shvartsbergs AM
Biull Eksp Biol Med; 1989 Jan; 107(1):74-7. PubMed ID: 2783655
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibodies IPO-4 recognizing antigen-activated human T and B lymphocytes].
Sidorenko SP; Berdova AG; Vetrova EP; Shlapatskaia LN; Iurchenko OV; Evsev'eva AI; Gluzman DF
Eksp Onkol; 1990; 12(3):21-4. PubMed ID: 2344819
[TBL] [Abstract][Full Text] [Related]
15. [Use of monoclonal antibodies and lectins in the study of subpopulations of lymphoid cells in normal state and in leukemia].
Nadgornaia VA; Skliarenko DM; Gluzman DF; Kaz'mina EV
Eksp Onkol; 1990; 12(4):51-3. PubMed ID: 2379488
[TBL] [Abstract][Full Text] [Related]
16. Potential use of the Macrobrachium rosenbergii lectin for diagnosis of T-cell acute lymphoblastic leukemia.
Pérez-Campos-Mayoral L; Ruiz-Argüelles A; Pérez-Romano B; Zenteno E; Hernández-Cruz P; Martínez-Cruz R; Martínez-Cruz M; Pina-Canseco S; Pérez-Campos E
Tohoku J Exp Med; 2008 Jan; 214(1):11-6. PubMed ID: 18212483
[TBL] [Abstract][Full Text] [Related]
17. [ICO-35 monoclonal antibodies to the antigen of acute lymphoblastic leukemia].
Baryshnikov AIu; Tupitsyn NN; Korotkova OV; Kadagidze ZG; Dostot E; Shmidt M; Boumsell L
Eksp Onkol; 1989; 11(5):52-3. PubMed ID: 2529115
[TBL] [Abstract][Full Text] [Related]
18. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
[TBL] [Abstract][Full Text] [Related]
19. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in pediatric B-cell acute lymphoblastic leukemia.
Wyatt KD; Bram RJ
Hum Immunol; 2019 Jun; 80(6):400-408. PubMed ID: 30716352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
